Keywords: astellas, merger, costs, cause, profit, drop, pharma

Astellas: merger costs cause 75% profit drop

Article | 30 May 2005

Print This

Astellas Pharma, Japan's second-largest drugmaker formed after last month's merger of Yamonouchi and Fujisawa, says that its profits for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in